Adverum Biotechnologies Inc (NASDAQ: ADVM) stock suffered a major decline of -12.4% on 4/1/25. The shares closed at $3.83. Moreover, unusually high trading volume at 160% of normal accompanied the decline. The stock has been extremely weak relative to the market over the last nine months and has declined -29.1% during the last week.
Current PriceTarget Research Rating
Adverum Biotechnologies has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Adverum Biotechnologies has a good Appreciation Score of 80 but a very low Power Rating of 9, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment